Evaluating Clinical Fit: Who Benefits From Self-Pay GLP-1 Access Uninsured GLP-1 candidates typically include adults with BMI 25+ and metabolic risk factors (elevated fasting glucose, family history of diabetes, weight-related comorbidities), those seeking preventive metabolic optimization, or patients with documented medication resistance to conventional weight management
Kocherova, A
Like PVCs, PACs are usually no cause for concern
UK Guidance for Surgery GLP-1 receptor agonists, such as semaglutide and liraglutide, are increasingly prescribed for type 2 diabetes and weight management in the UK
Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells
*Correspondence: Peter Kramer, [email protected], orcid.org/0000-0003-4807-7077 This article was submitted to Aging Neuroscience Archive, a section of the journal Frontiers in Aging Neuroscience Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
